Auditors, lawyers, tax consultants and management consultants: Four perspectives. One solution. Worldwide. Find out …
We review your past and advise you on the implementation of future requirements and projects. Find out more!
Our clients entrust us with their most important legal matters. Learn more about our legal services!
Tax laws are complex and dynamic. We face the challenge of tax law together with you - find out more.
We support you with customised solutions so that your company can continue to operate successfully on the market in …
Tax challenges for German companies operating internationally
Deemed Supply Chain: VAT Risks with Third-Country Connections
Pay slips are purely information documents
EU “Omnibus” Package: Less effort for sustainability reporting?
Baker Tilly starts the year 2025 with 23 new Directors
Challenges in corporate finance: Baker Tilly at Structured FINANCE 2024
BAG overturns forfeiture clause for share options after termination
Art. 273a ZPO: More protection for trade secrets in civil proceedings
Baker Tilly advises CFL on container vessel acquisition
Public procurement: Legally compliant procurement of cyber insurance
Countdown to September – The EU Data Act and its implications
Procurement law – legal framework for emergency procurements in the event of a cyberattack
Industry-specific knowledge is essential in order to create the best conditions for customised solutions. Find out …
Baker Tilly advises biotech startup Real Collagen GmbH investment by US investor
Energy study: Uncertainty slows down investments by industry and utilities in Germany
After ECJ ruling: Financial investors still have no direct access to medical care centers
Benefit from bundled interdisciplinary competencies, expert teams and individual solutions. Learn more!
Baker Tilly offers a wide range of individual and innovative consulting services. Find out more!
Medical progress, cost pressure and a complex general framework require flexible and customized solutions – with our interdisciplinary expertise, we support hospitals, care facilities, health insurance companies and companies in the life science and healthcare sector to increase efficiency, reduce costs and ensure sustainable growth.
The healthcare industry and the biotech sector regularly stand out as drivers of the economy or as growth sectors of the 21st century. The reasons for this are obvious; ageing populations in Europe and China, for example, an increasing number of people suffering from civilization-related illnesses and a high demand for personalized medicine and biotechnology (TechBio) are leading to a sharp rise in demand for the services offered by these industries. This trend is significantly influenced by steadily rising cost pressure and a decline in the availability of skilled workers – in particular in the healthcare sector.
While the pharmaceutical and life science sector can also frequently fall back on private equity financing, traditional acute healthcare has been underfunded for many years, with the result that the “dual financing” provided for by law has long since given way to shortage management in practice. On the one hand, this has led to high margin pressure on existing payers in the health and care sector and to a sharp increase in consolidation in the healthcare sector. While hospitals and medical care centers were operated by state institutions in the past, private equity is now increasingly investing in this sector.
Innovative strategies
Medical progress, cost pressure and a complex general framework require flexibility and forward-looking solutions – we support hospitals, care facilities and health insurance companies with intelligent models and efficient structures.
Securing value enhancement
We support companies in the life science and healthcare sector with tailored advice and interdisciplinary expertise in order to increase efficiency, reduce costs and ensure sustainable growth in a dynamic industry.